in-Pharmatechnologist spoke with McCrone VP of instrument sales Jeff McGinn at AAPS 2010 in New Orleans who explained that increasingly strict regulatory quality requirements are driving demand for both scanning electron microscopy and traditional light microscopy.
He explained that drugmakers are seeking to increase microscopy capacity to accelerate the quality analysis process, choosing systems capable of analysing everything from coatings to surface porosity of drugs taken from the production line.